Cancer Communications

Important notice

Cancer Communications will cease to publish with BioMed Central on 31^st December 2019. The journal is continuing in cooperation with a new publisher, Wiley starting from 2020. The new journal website is available at: https://onlinelibrary.wiley.com/journal/25233548.

The current submission site will be inactive on 31^st October 2019. Any new or revised manuscripts submitted after 1^st November 2019 should go to the new site: https://mc.manuscriptcentral.com/cac2. Please contact the editorial office at cancercommun@sysucc.org.cn for information regarding the new publisher and any submissions in progress.

Articles

Minimally invasive surgery alone compared with intensity-modulated radiotherapy for primary stage I nasopharyngeal carcinoma

Authors: You-Ping Liu, Xing Lv, Xiong Zou, Yi-Jun Hua, Rui You, Qi Yang, Le Xia, Shao-Yan Guo, Wen Hu, Meng-Xia Zhang, Si-Yuan Chen, Mei Lin, Yu-Long Xie, Li-Zhi Liu, Rui Sun, Pei-Yu Huang…

Content type: Original article

15 November 2019
Tumor mutational burden as a new biomarker for PD-1 antibody treatment in gastric cancer

Authors: Gunnar Folprecht

Content type: Research highlight

14 November 2019
Neoadjuvant stereotactic radiosurgery for intracerebral metastases of solid tumors (NepoMUC): a phase I dose escalation trial

Authors: Christian D. Diehl, Ehab Shiban, Christoph Straube, Jens Gempt, Jan J. Wilkens, Markus Oechsner, Carmen Kessel, Claus Zimmer, Benedict Wiestler, Bernhard Meyer and Stephanie E. Combs

Content type: Study Protocol

9 November 2019
Moving beyond hydroxychloroquine: the novel lysosomal autophagy inhibitor ROC-325 shows significant potential in preclinical studies

Authors: Trace M. Jones, Claudia Espitia, Wei Wang, Steffan T. Nawrocki and Jennifer S. Carew

Content type: Research highlight

9 November 2019
Nuclear glycogenolysis modulates histone acetylation: a novel mechanism of epigenetic regulation in cancer

Authors: Xifeng Dong

Content type: Research highlight

9 November 2019

Most recent articles RSS

View all articles

Predictive biomarkers in precision medicine and drug development against lung cancer

Authors: Bingliang Fang, Reza J Mehran, John V Heymach and Stephen G Swisher

Content type: Review

2 July 2015
The prognostic value of serum C-reactive protein-bound serum amyloid A in early-stage lung cancer

Authors: Xue-Yan Zhang, Ge Zhang, Ying Jiang, Dan Liu, Man-Zhi Li, Qian Zhong, Shan-Qi Zeng, Wan-Li Liu and Mu-Sheng Zeng

Content type: Original article

10 August 2015
Subdivision of M category for nasopharyngeal carcinoma with synchronous metastasis: time to expand the M categorization system

Authors: Lu-Jun Shen, Si-Yang Wang, Guo-Feng Xie, Qi Zeng, Chen Chen, An-Nan Dong, Zhi-Mei Huang, Chang-Chuan Pan, Yun-Fei Xia and Pei-Hong Wu

Content type: Original article

12 August 2015
Cytochrome b5 reductase 2 suppresses tumor formation in nasopharyngeal carcinoma by attenuating angiogenesis

Authors: Huixin Ming, Ying Lan, Feng He, Xue Xiao, Xiaoying Zhou, Zhe Zhang, Ping Li and Guangwu Huang

Content type: Original article

15 August 2015
Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?

Authors: Rui-Mei Feng, Yi-Nan Zong, Su-Mei Cao and Rui-Hua Xu

Content type: Short report

29 April 2019

Most accessed articles RSS

View all articles

2018

Thematic series
Boron Neutron Capture Therapy of Cancer
Edited by Rolf F. Barth

2017

Thematic series
Tumor Metastasis
Edited by Jian Zhang and Chao-Nan Qian

2016

Thematic series
Gastric Cancer
Edited by Yun Dai and Li Yan

Thematic series
Tumor Angiogenesis
Edited by Francesco Pezzella and Chao-Nan Qian

2015

Thematic series
Lung Cancer
Edited by Lin Yan and Wei Zhang

Archival content

To browse articles published in the journal prior to March 2015, please visit the Sun Yat-sen University Cancer Center website.

Thematic series

Boron Neutron Capture Therapy of Cancer
Edited by Rolf F. Barth

Tumor metastasis
Edited by: Jian Zhang and Chao-Nan Qian

Aims and scope

Cancer Communications is an open access, peer-reviewed online journal that encompasses basic, clinical, and translational cancer research. The journal welcomes submissions concerning clinical trials, epidemiology, molecular and cellular biology, and genetics.

Editor-in-Chief

Prof Rui-Hua Xu, Sun Yat-sen University Cancer Center, China

Information for authors

Cancer Communications offers waivers to authors for selected high quality articles. For rapid feedback on the potential suitability of an article for waiver, please send a pre-submission enquiry to the editorial office, providing the article title, abstract and a brief cover letter.

Cancer Communications

Important notice

Articles

Minimally invasive surgery alone compared with intensity-modulated radiotherapy for primary stage I nasopharyngeal carcinoma

Tumor mutational burden as a new biomarker for PD-1 antibody treatment in gastric cancer

Neoadjuvant stereotactic radiosurgery for intracerebral metastases of solid tumors (NepoMUC): a phase I dose escalation trial

Moving beyond hydroxychloroquine: the novel lysosomal autophagy inhibitor ROC-325 shows significant potential in preclinical studies

Nuclear glycogenolysis modulates histone acetylation: a novel mechanism of epigenetic regulation in cancer

Predictive biomarkers in precision medicine and drug development against lung cancer

The prognostic value of serum C-reactive protein-bound serum amyloid A in early-stage lung cancer

Subdivision of M category for nasopharyngeal carcinoma with synchronous metastasis: time to expand the M categorization system

Cytochrome b5 reductase 2 suppresses tumor formation in nasopharyngeal carcinoma by attenuating angiogenesis

Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?

2018

2017

2016

2015

Archival content

Thematic series

Aims and scope

Editor-in-Chief

Information for authors

Affiliated with

Follow

Annual Journal Metrics

Cancer Communications

Contact us